The transaction comes more than a year after Romania’s Competition Council decided that Affidea must forgo four out of 23 Hiperdia clinics acquired in areas at risk of economic concentration.
The four Hiperdia centers acquired by Regina Maria are Hiperdia Arad, Orastie, Cluj Observatorului and Cluj Medicala 3.
The value of the transaction was not disclosed.
The antitrust watchdog raised antitrust concerns regarding a potential dominant position of the company resulted from an economic concentration on the mentioned markets.
Affidea, a leading provider of medical imaging and cancer treatment services in Europe, signed in 2017 a binding agreement for the acquisition of diagnostic centers Hiperdia, which operates 23 medical centers located in 12 counties across Romania, boasting a turnover of RON77 million. The official value of the transaction was not disclosed, but people close to the matter say it amounts to EUR40-50 million, considering the acquisition of a majority stake in Hiperdia.